Abortion Pill Manufacturers Appeal to Supreme Court Over Mail-Order Access

Sun, 03 May 2026 10:03:00 +0200

Two pharmaceutical companies, Danco Laboratories and GenBioPro, have petitioned the U.S. Supreme Court to reinstate mail-order access to mifepristone, an abortion pill that is used in about two-thirds of U.S. abortions. The request follows a temporary decision by the 5th U.S. Circuit Court of Appeals to block mail-order deliveries, which significantly limits access to the medication, especially in states where abortion is banned. The ruling has raised concerns among healthcare providers and patients, who face confusion about the legal status of the drug. The appeal is part of a larger legal battle over the FDA’s approval and regulation of mifepristone, which has been in the spotlight since the Supreme Court’s 2022 decision overturning Roe v. Wade. The case underscores the ongoing challenges to abortion access across the U.S., with several states pushing for stricter controls on medication abortion. The Supreme Court is expected to review the case soon, and its decision will have signif